GH1 and Prader-Willi syndrome: Although somatotropin treatment constitutes a great change in the treatment of individuals with PWS during the last three decades and is believed to have positive effects on general health, the lack of clinical data prevents us from making reliable statistical analyses comparing different age groups with regard to somatotropin treatment and outcomes.